Theatre Is a Valid Add-On Therapeutic Intervention for Emotional Rehabilitation of Parkinson's Disease Patients

Giovanni Mirabella, Paolo De Vita, Michele Fragola, Silvia Rampelli, Francesco Lena, Fulvia Dilettuso, Marta Iacopini, Raffaella d'Avella, Maria Concetta Borgese, Silvia Mazzotta, Deborah Lanni, Marco Grano, Sara Lubrani, Nicola Modugno, Giovanni Mirabella, Paolo De Vita, Michele Fragola, Silvia Rampelli, Francesco Lena, Fulvia Dilettuso, Marta Iacopini, Raffaella d'Avella, Maria Concetta Borgese, Silvia Mazzotta, Deborah Lanni, Marco Grano, Sara Lubrani, Nicola Modugno

Abstract

Conventional medical treatments of Parkinson's disease (PD) are effective on motor disturbances but may have little impact on nonmotor symptoms, especially psychiatric ones. Thus, even when motor symptomatology improves, patients might experience deterioration in their quality of life. We have shown that 3 years of active theatre is a valid complementary intervention for PD as it significantly improves the well-being of patients in comparison to patients undergoing conventional physiotherapy. Our aim was to replicate these findings while improving the efficacy of the treatment. We ran a single-blinded pilot study lasting 15 months on 24 subjects with moderate idiopathic PD. 12 were assigned to a theatre program in which patients underwent "emotional" training. The other 12 underwent group physiotherapy. Patients were evaluated at the beginning and at the end of their treatments, using a battery of eight clinical and five neuropsychological scales. We found that the emotional theatre training improved the emotional well-being of patients, whereas physiotherapy did not. Interestingly, neither of the groups showed improvements in either motor symptoms or cognitive abilities tested by the neuropsychological battery. We confirmed that theatre therapy might be helpful in improving emotional well-being in PD.

Figures

Figure 1
Figure 1
Mean scores and standard error of the means at the two time points for the theatre (gray bars) and control group (black bars) in the scales or subscales showing a significant effect at the mixed-design ANOVAs (see text and Table 5 for more details). Bars indicate significant differences after post hoc analyses, the single indicates values of p < 0.01, and the double indicates values of p < 0.001. PDQ39: Parkinson's Disease Quality of Life Scale; PDSS: Parkinson's Disease Sleep Scale.

References

    1. Chaudhuri K. R., Schapira A. H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. The Lancet Neurology. 2009;8(5):464–474. doi: 10.1016/S1474-4422(09)70068-7.
    1. Postuma R. B., Montplaisir J. Predicting Parkinson's disease—why, when, and how? Parkinsonism & Related Disorders. 2009;15(supplement 3):S105–S109. doi: 10.1016/S1353-8020(09)70793-X.
    1. Cotzias G. C., Papavasiliou P. S., Gellene R. L-dopa in parkinson's syndrome. The New England Journal of Medicine. 1969;281(15):p. 272.
    1. Fahn S. The history of dopamine and levodopa in the treatment of Parkinson's disease. Movement Disorders. 2008;23(supplement 3):S497–S508. doi: 10.1002/mds.22028.
    1. Lang A. E., Lozano A. M. Parkinson's disease. First of two parts. The New England Journal of Medicine. 1998;339(15):1044–1053. doi: 10.1056/NEJM199810083391506.
    1. Bohannon R. W. Physical rehabilitation in neurologic diseases. Current Opinion in Neurology. 1993;6(5):765–772. doi: 10.1097/00019052-199310000-00015.
    1. Tickle-Degnen L., Ellis T., Saint-Hilaire M. H., Thomas C. A., Wagenaar R. C. Self-management rehabilitation and health-related quality of life in Parkinson's disease: a randomized controlled trial. Movement Disorders. 2010;25(2):194–204. doi: 10.1002/mds.22940.
    1. Tomlinson C. L., Patel S., Meek C., et al. Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database of Systematic Reviews. 2012;8CD002817
    1. Carne W., Cifu D. X., Marcinko P., et al. Efficacy of multidisciplinary treatment program on long-term outcomes of individuals with Parkinson's disease. Journal of Rehabilitation Research and Development . 2005;42(6):779–786. doi: 10.1682/JRRD.2005.03.0054.
    1. Olanow C. W., Stern M. B., Sethi K. The scientific and clinical basis for the treatment of Parkinson disease. Neurology. 2009;72(21):S1–S136. doi: 10.1212/WNL.0b013e3181a1d44c.
    1. Bach J.-P., Ziegler U., Deuschl G., Dodel R., Doblhammer-Reiter G. Projected numbers of people with movement disorders in the years 2030 and 2050. Movement Disorders. 2011;26(12):2286–2290. doi: 10.1002/mds.23878.
    1. Li F., Harmer P., Fitzgerald K., et al. Tai chi and postural stability in patients with Parkinson's disease. The New England Journal of Medicine. 2012;366(6):511–519. doi: 10.1056/nejmoa1107911.
    1. Hackney M. E., Earhart G. M. Effects of dance on movement control in Parkinson’s disease: a comparison of Argentine tango and American ballroom. Journal of Rehabilitation Medicine. 2009;41(6):475–481. doi: 10.2340/16501977-0362.
    1. Volpe D., Signorini M., Marchetto A., Lynch T., Morris M. E. A comparison of Irish set dancing and exercises for people with Parkinson's disease: a phase II feasibility study. BMC Geriatrics. 2013;13(1, article 54) doi: 10.1186/1471-2318-13-54.
    1. Pacchetti C., Mancini F., Aglieri R., Fundaró C., Martignoni E., Nappi G. Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosomatic Medicine. 2000;62(3):386–393. doi: 10.1097/00006842-200005000-00012.
    1. Sproesser E., Viana M. A., Quagliato E. M. A. B., de Souza E. A. P. The effect of psychotherapy in patients with PD: a controlled study. Parkinsonism & Related Disorders. 2010;16(4):298–300. doi: 10.1016/j.parkreldis.2009.08.008.
    1. Armento M. E. A., Stanley M. A., Marsh L., et al. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. Journal of Parkinson's Disease. 2012;2(2):135–151. doi: 10.3233/jpd-2012-12080.
    1. Foster E. R., Bedekar M., Tickle-Degnen L. Systematic review of the effectiveness of occupational therapy-related interventions for people with Parkinson's disease. The American Journal of Occupational Therapy. 2014;68(1):39–49. doi: 10.5014/ajot.2014.008706.
    1. Modugno N., Iaconelli S., Fiorilli M., Lena F., Kusch I., Mirabella G. Active theater as a complementary therapy for Parkinson's disease rehabilitation: a pilot study. The Scientific World Journal. 2010;10:2301–2313. doi: 10.1100/tsw.2010.221.
    1. Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Frontiers in Psychology. 2013;4(article 863) doi: 10.3389/fpsyg.2013.00863.
    1. Müller B., Assmus J., Herlofson K., Larsen J. P., Tysnes O.-B. Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. Parkinsonism & Related Disorders. 2013;19(11):1027–1032. doi: 10.1016/j.parkreldis.2013.07.010.
    1. Santos-García D., de la Fuente-Fernández R. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease. Journal of the Neurological Sciences. 2013;332(1-2):136–140. doi: 10.1016/j.jns.2013.07.005.
    1. Forsaa E. B., Larsen J. P., Wentzel-Larsen T., Herlofson K., Alves G. Predictors and course of health-related quality of life in Parkinson's disease. Movement Disorders. 2008;23(10):1420–1427. doi: 10.1002/mds.22121.
    1. Mirabella G. Should I stay or should I go? Conceptual underpinnings of goal-directed actions. Frontiers in Systems Neuroscience. 2014;8(206) doi: 10.3389/fnsys.2014.00206.
    1. Mazzoni P., Hristova A., Krakauer J. W. Why don't we move faster? Parkinson's disease, movement vigor, and implicit motivation. The Journal of Neuroscience. 2007;27(27):7105–7116. doi: 10.1523/JNEUROSCI.0264-07.2007.
    1. Tinaz S., Pillai A. S., Hallett M. Sequence effect in Parkinson's disease is related to motor energetic cost. Frontiers in Neurology. 2016;7(83) doi: 10.3389/fneur.2016.00083.
    1. Rutledge R. B., Skandali N., Dayan P., Dolan R. J. Dopaminergic modulation of decision making and subjective well-being. The Journal of Neuroscience. 2015;35(27):9811–9822. doi: 10.1523/JNEUROSCI.0702-15.2015.
    1. Bega D., Gonzalez-Latapi P., Zadikoff C., Simuni T. A review of the clinical evidence for complementary and alternative therapies in parkinson’s disease. Current Treatment Options in Neurology. 2014;16(10, article 314) doi: 10.1007/s11940-014-0314-5.
    1. Mirabella G. Is art therapy a reliable tool for rehabilitating people suffering from brain/mental diseases? The Journal of Alternative and Complementary Medicine. 2015;21(4):196–199. doi: 10.1089/acm.2014.0374.
    1. Elbert T., Pantev C., Wienbruch C., Rockstroh B., Taub E. Increased cortical representation of the fingers of the left hand in string players. Science. 1995;270(5234):305–307. doi: 10.1126/science.270.5234.305.
    1. Lebedev M. A., Mirabella G., Erchova I., Diamond M. E. Experience-dependent plasticity of rat barrel cortex: redistribution of activity across barrel-columns. Cerebral Cortex. 2000;10(1):23–31. doi: 10.1093/cercor/10.1.23.
    1. Hurt C. S., Weinman J., Lee R., Brown R. G. The relationship of depression and disease stage to patient perceptions of Parkinson's disease. Journal of Health Psychology. 2012;17(7):1076–1088. doi: 10.1177/1359105311428537.
    1. Gorini A., Gaggioli A., Vigna C., Riva G. A second life for eHealth: prospects for the use of 3-D virtual worlds in clinical psychology. Journal of Medical Internet Research. 2008;10(3, article e21) doi: 10.2196/jmir.1029.

Source: PubMed

3
S'abonner